Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1989-07-27
1991-02-19
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
514530, A61K 3122, A61K 31215, A61K 3119
Patent
active
049942743
ABSTRACT:
Compounds and their use for lowering intraocular pressure are disclosed herein.
REFERENCES:
patent: 3853854 (1974-12-01), Weinshenker et al.
patent: 3940438 (1976-02-01), Weinshenker
patent: 3941886 (1976-03-01), Weinshenker
patent: 4001306 (1977-01-01), Morozowich et al.
patent: 4016184 (1977-04-01), Morton, Jr.
patent: 4033989 (1977-07-01), Bundy
patent: 4049678 (1977-09-01), Peterson
patent: 4055593 (1977-10-01), Weinshenker et al.
patent: 4060540 (1977-11-01), Barnady et al.
patent: 4099014 (1978-07-01), Peterson
patent: 4599353 (1986-07-01), Bito
patent: 4822819 (1989-04-01), DeSantis et al.
patent: 4824857 (1989-04-01), Goh et al.
patent: 4883819 (1989-11-01), Bito
Jenny, Erwin and Schaublin, Peter Tetrahedron Letters 26: 2235-2238 (1974).
Kondo, Kiyosi et al., Tetrahedron Letters, 41: 3927-3930 (1978).
Gandolfo, C. et al., Farmaco. Ed. Sci. 27: 1125-1129 (1972).
Andersen, Neils, Prostaglandin 6(5): 361-374 (1974).
Chem., Biochem., Pharmacol. Act Prostanoids, INCL. Proc. Symp., Meeting Date 1978, pp. 185-193; ed. Roberts, Stanley N. and Scheinman, Theodore; Pergamon Press (1979).
Bito, Arch. Ophthalmol. 105, (1987).
Camras et al., Invest. Ophthalmol. Vis. Sci. 16, 1125 (1977).
Keun Kim, Investigative Ophthalmology 14, 36 (1975).
Nilsson et al., Exp. Eye Res. 48, 707 (1989).
Siebold et al., Prodrug 5, 3 (1989).
Starr, Exp. Eye Res. 11, 170-177 (1971).
Zajacz et al., The Eye: Reproduction, Obstetrics and Gynecology 4, 316 (1976).
Chan Ming F.
Woodward David F.
Allergan Inc.
Cashion Jr. Merrell C.
Mills Demetra J.
LandOfFree
Intraocular pressure reducing 11,15-diacyl prostaglandins and me does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intraocular pressure reducing 11,15-diacyl prostaglandins and me, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intraocular pressure reducing 11,15-diacyl prostaglandins and me will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1142271